AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02554825 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Healthy Futures
Description: Healthy Futures is an age-appropriate program that targets change at different social ecological levels-individual, interpersonal, and organizational. The main component is a classroom-based relationship education curriculum, Nu-CULTURE, offered in 6th, 7th, and 8th grade for eight 50-minute sessions each year. A number of supplemental efforts aim to enhance the Nu-CULTURE program and create social supports: 1) virtual classrooms where participating youth are encouraged to visit age-appropriate youth websites; 2) daily interactive parental connection forms linked with Nu-CULTURE, a parent website, and workshops (True Connections); 3) a 10-week after-school program, Rhymin' it Write, encourages youth leadership; 4) a 6-week summer program, Code A, engages youth during out-of-school time after 8th grade.
Study NCT02554825 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Control
Description: The Control Curriculum offers students in the control group two 50-minute classes each year on general health education topics. Students in the 6th grade receive a class on puberty/reproduction and a class on bullying prevention; students in the 7th grade receive two classes on dating-violence prevention; and students in the 8th grade receive two classes on mental health promotion.
Study NCT03232749 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: intraarticular corticosteroid injections (IACSI)
Description: ultrasound-guided IACSI will be administered
Study NCT03232749 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: corticosteroid injections
Description: Corticosteroid will be administered is used to treat pain and swelling that occurs with arthritis and other joint disorder
Study NCT03232749 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Ultrasound
Description: ultrasound-guided IACSI
Study NCT03654092 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Home-based exercise training program that requires only minimal equipment, and is individually adaptable to the participant's exercise level (6 times per week; 15-20 min; 38 exercise cards and one interactive training agenda booklet). After randomization, a health care professional (HOMEX coach) will visit the intervention group participants at their home to set up the training location, to instruct the exercises and to establish individualized goals. Follow-up visits are planned after 3 and 8-9 weeks. Regular telephone calls will be conducted by the same HOMEX coach to motivate the patients, to discuss training progress and concrete benefits and barriers, and to adapt goals and the training program. Additional intervention elements are that a relative or friend is involved as a sparring partner to support the participant. The general practitioner is informed about the participation of his/her patient in the intervention.
Study NCT03429374 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Liquiband Fix8
Description: LiquiBand® Fix 8™ (Advanced Medical Solutions - Plymouth, UK) is a hernia mesh fixation device providing strong and secure mesh fixation without causing any tissue damage or mechanical trauma. This device is designed to offer precise and controlled delivery of tissue glue (n-butyl-2-cyanoacrylate), resulting in a strong mesh fixation.
Study NCT03429374 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Absorbable tack
Description: Absorbable tack
Study NCT03362528 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: WM3.4NR
Description: Investigational Medical Device collecting spectral raman data from tissue.
Study NCT00782275 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: bevacizumab
Study NCT00782275 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: temsirolimus
Study NCT03386669 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: F-18
Description: Totally 60 subjects age 20-80 including 20 subjects with a diagnosis of PD,PSP,and CBS. For disease subjects, caregiver should be able to report activities of daily living and their mental status. Patient should be able to give informed consent or have a caregiver give consent with subject assent.
Study NCT04120714 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active tDCS
Description: active D.C. transcranial stimulation (delivers a low current (1 to 2 mA)) for 10 to 30 minutes, during 5 sessions
Study NCT04120714 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo tDCS
Description: inactive DC transcranial stimulation (delivering a non-significant current at the beginning and end of the stimulation, simulating active stimulation) for 10 to 30 minutes, during 5 sessions
Study NCT04120714 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaires
Description: * visual analogue scale (VAS)~* impulsivity scale: Barratt Impulsiveness Scale - version 11 (BIS-11)~* Decision-making scales: Iowa Gambling Task (IGT) and Balloon Analogue Risk Task (BART)~* Go-No go test~* HAM-D scale~* SF-12 quality of life scale
Study NCT04120714 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Questionnaires
Description: * visual analogue scale (VAS)~* impulsivity scale: Barratt Impulsiveness Scale - version 11 (BIS-11)~* Decision-making scales: Iowa Gambling Task (IGT) and Balloon Analogue Risk Task (BART)~* Go-No go test~* HAM-D scale~* SF-12 quality of life scale
Study NCT01632683 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: C-MAC
Description: C-MAC arm
Study NCT01632683 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Glidescope
Description: Glidescope arm
Study NCT02353299 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Silenor 6 mg
Description: Silenor 6 mg single nighttime dose.
Study NCT02353299 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Silenor 6 mg
Description: Silenor 6 mg single nighttime dose.
Study NCT02353299 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: zolpidem 10 mg
Description: Zolpidem 10 mg single nighttime dose
Study NCT02353299 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: zolpidem 10 mg
Description: Zolpidem 10 mg single nighttime dose
Study NCT02353299 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo single nighttime dose-1.5 hours
Study NCT02353299 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: placebo single nighttime dose-1.5 hours
Study NCT02353299 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo single nighttime dose-4 hours
Study NCT02353299 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: placebo single nighttime dose-4 hours
Study NCT00216125 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Cisplatin
Description: Cisplatin 50 mg/m2 day 1, 8, 29, 36
Study NCT00985218 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SMART System
Description: microfluidic embryo culture system
Study NCT00985218 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Culture dish
Description: Standard IVF culture dish
Study NCT02353793 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ReadyHeat® blanket
Description: Using ReadyHeat® blanket for patient warming
Study NCT02353793 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Cotton wool blanket
Description: Using cotton wool blanket for patient warming
Study NCT02324491 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ZGN-440 for Injectable Suspension
Description: Subjects will receive ZGN-440 twice weekly subcutaneous injections for up to 52 weeks.
Study NCT02324491 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: ZGN-440 Placebo for Injectable Suspension
Description: Subjects will receive placebo twice weekly subcutaneous injections for up to 52 weeks.
Study NCT04442555 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: HVMN Ketone Ester
Description: Commercially available ketone supplement
Study NCT04442555 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Maltodextrin
Description: Commercially available maltodextrin supplement
Study NCT02639702 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clozapine
Description: Switching from twice-daily to once-daily clozapine dosing regimen
Study NCT02206529 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Social Network Engagement+Std Treatment
Study NCT02206529 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Standard Treatment
Description: Standard Treatment = family-based behavioral pediatric obesity treatment, as per protocol outlined in FOCUS trial (Family Overweight: Comparing Use of Strategies; NCT00746629)
Study NCT05016492 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Visual-perceptual interactive game system
Description: Subjects received 30-min interactive digital game training session per week. The game system contain 7 skills training, each of which was named according to the corresponding TVPS-3.
Study NCT05016492 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: standard rehabilitation
Description: Subjects received the standard 4-week course of rehabilitation delivered in one 30-min session per week. The course of rehabilitation included: sensory integration therapy, cognitive function training and visual perception/auditory attention training.
Study NCT05016492 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: standard rehabilitation
Description: Subjects received the standard 4-week course of rehabilitation delivered in one 30-min session per week. The course of rehabilitation included: sensory integration therapy, cognitive function training and visual perception/auditory attention training.
Study NCT02706457 — intervention group
Intervention type: OTHER
Intervention: Barthel index for functionality
Description: The Barthel Index for functionality is done standard in all patients after intensive care admission
Study NCT00221793 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Deep brain stimulation
Description: Brain Stimulation of the Subthalamic Nucleus
Study NCT00221793 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Deep brain stimulation
Description: Brain Stimulation of the Subthalamic Nucleus
Study NCT00829439 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levodopa/Carbidopa (4:1)
Description: Dosages are based on levodopa.~Each cohort of 3 subjects will be placed on an increasing dose of levodopa (2, 5, 10, and 15 mg/kg/day) for 1 week, provided subjects in the preceding cohort tolerated the lower dose.~Levodopa/Carbidopa is a combined formulation that will be dispensed as capsules. It should be taken 3 times a day.
Study NCT04071392 — intervention group
Intervention type: PROCEDURE
Intervention: Hysterosalpingogram (HSG)
Description: An infusion pump delivered saline via balloon catheter under continuous pressure monitoring. After one minute, investigators withdraw the fluid and recorded volumes in and out. Subjects then undergo hysterosalpingogram (HSG) for evaluation of tubal patency.
Study NCT03413969 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CREATION
Description: The physician-oriented intervention will consist of a two-day weekend retreat that focuses on the application of CREATION Health principles in order to reduce burnout and perceived stress and improve well-being and empathy. There will be one four-hour session about each of the following CREATION Health principles: Choice, Trust, Interpersonal Relationships, and Outlook.
Study NCT00921804 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD 8529
Description: 40mg oral daily capsule administered as a single dose in the morning for 28 days
Study NCT00921804 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Risperidone
Description: 4mg (2mg on Day 1) oral daily capsule administered as a single dose in the evening for 28 days
Study NCT00921804 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo to match AZD8529
Description: Placebo to match AZD8529 administered as a daily capsule in the morning for 28 days during the treatment period and also during the 3-7 day washout or run-in period
Study NCT00921804 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Placebo to match AZD8529
Description: Placebo to match AZD8529 administered as a daily capsule in the morning for 28 days during the treatment period and also during the 3-7 day washout or run-in period
Study NCT00921804 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to match risperidone
Description: Placebo to match risperidone administered as a daily capsule in the evening for 28 days during the treatment period and also during the 3-7 day washout or run-in period
Study NCT00921804 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo to match risperidone
Description: Placebo to match risperidone administered as a daily capsule in the evening for 28 days during the treatment period and also during the 3-7 day washout or run-in period
Study NCT04708873 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High intensity interval training
Description: 4x4 min intervals of high intensity treadmill running (80-95% of HRR, RPE 7-10 on Borg's category ratio scale of perceived exertion) interspersed with active recovery (slow jogging or fast walking at 50-70% HRR). HIIT-Resistance exercises 2 sessions per week, RPE 5 (hard) 6-8 RM, 1-3 sets of as many repetitions as possible in 60 seconds, active recovery 20-60 seconds b/w exercises,
Study NCT04708873 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Moderate Intensity Continuous Training
Description: Moderate intensity continuous Aerobic exercises (Stationary cycling for 15-20 min followed by treadmill walking for 15-20 min) at 55-70% 55-70% of HRR, RPE 3-4 on Borg's category ratio scale of perceived exertion. The session will be preceded by 5-7 minute warm-up \&amp; 7-10 min cool-down.
Study NCT03066531 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ACT-based intervention
Study NCT03066531 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: CBT-based intervention
Study NCT01856231 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lifestyle physical activity - self-efficacy
Description: Subjects will come into an exercise lab 2 days per week and perform 10-20 minutes of walking, 13 strength training exercises, stretching and a behavioral intervention including goal setting, etc.
Study NCT02044965 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Antibiotic
Description: 2 mg/kg per day via oral ingestion.
Study NCT02194621 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Total Flavor option 1
Description: Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 1 ingredient -Total Flavor Option 1
Study NCT02044965 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Antibiotic
Description: 2 mg/kg per day via oral ingestion.
Study NCT02044965 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Probiotic
Description: 2 capsules; 5 billion total organisms of L. rhamnosus GR-1 and L. reuteri RC-14 per capsule
Study NCT02044965 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Probiotic
Description: 2 capsules; 5 billion total organisms of L. rhamnosus GR-1 and L. reuteri RC-14 per capsule
Study NCT01837485 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lactol
Description: The Symbiotic Lactol® (Bioplus Life Sciences Pvt.) was applied 3 times a day for 3 months. Lactol is composed of the followings; Lactobacillus Sporogenes (15 × 107 Spores), Fructo-Oligosaccharides, Microcrystalline Cellulose, Sodium starch Glycolate, Povidone, Hypermellose Stearate, Sillicon Dioxide, and Propylene Glycol.
Study NCT02194621 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Total Flavor option 2
Description: Total toothpaste containing triclosan/copolymer/sodium fluoride and new OM complex 2 ingredient. Total Flavor option 2
Study NCT01837485 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo pill was applied 3 times a day for 3 months
Study NCT02711189 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxytocin
Description: Oxytocin nasal spray given in dose 80
Study NCT02711189 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT02194621 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo toothpaste: Crest Cavity Protection toothpaste
Description: Placebo toothpaste: Crest Cavity Protection toothpaste w/sodium fluoride (currently marketed)
Study NCT02641548 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sock of silicone
Study NCT02641548 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Heel cream
Study NCT02641548 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Heel cream
Study NCT01162018 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: acupuncture
Description: The eligible women would be randomized and stratified by sleep problems to two arms: (Acupuncture Arm vs. Sham Acupuncture) with a goal of having 48 patients complete the study (we anticipate about 20% attrition rate). The study interventions will begin after patients completed their treatment. The placebo control for acupuncture will be a validated sham acupuncture control Assessments will be made with daily diaries and with weekly questionnaires. There are ten sessions each lasting approximately 20 minutes. All participants will have PSG data collected.
Study NCT01162018 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: placebo
Study NCT02832882 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: No-touch RFA
Description: No-touch RFA indicates RFA without tumor puncture. In this study, no-touch RFA is performed using Octopus electrodes.
Study NCT02832882 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional tumor puncture RFA
Description: Conventional tumor puncture RFA indicates routine procedure of RFA in our institution. In this study, RFA procedure is performed using Octopus electrodes.
Study NCT03819335 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: mySugr app
Description: mySugr is a mobile medical app for diabetes management. It has been developed by Roche Diabetes Care and it has two versions, free and Pro. It allows to carry out the diary of diabetes, including the collection and analysis of data on glycaemia, food, physical activity or insulin dose. In addition, it is compatible with continuous glucose measurement systems. It has the possibility to add functionalities such as estimation of HbA1c levels, more detailed data analysis or integration with Google Fit type motion sensors, as well as a bolus calculator, reminders for measuring blood glucose or photo gallery in the Pro version, which is the one that will be provided to the patients for the study.
Study NCT03819335 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard care
Description: Face-to-face visits
Study NCT02524704 — intervention group
Intervention type: DEVICE
Intervention: CT scan
Description: Applied only when part of the patient's standard care
Study NCT03447418 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Multiple breath nitrogen washout
Description: Lung Clearance Index (LCI) will be performed in healthy volunteers with a multiple breath nitrogen washout device.
Study NCT02170168 — intervention group
Intervention type: OTHER
Intervention: integrated palliative care program
Description: a standardised care pathway, an educational programme and information to general public, patients and their carers
Study NCT01222559 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: co.don chondrosphere®
Description: co.don chondrosphere® are spheroids in suspension, developed from autologous chondrocytes. The dose depends on the size of the defect, recommended dose is 10-70 spheroids/cm2 defect.
Study NCT01222559 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: co.don chondrosphere®
Description: co.don chondrosphere® are spheroids in suspension, developed from autologous chondrocytes. The dose depends on the size of the defect, recommended dose is 10-70 spheroids/cm2 defect.
Study NCT01222559 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Microfracture
Description: A procedure in which the subchondral bone is perforated to allow a bloodcloth to form new tissue.
Study NCT03954964 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Education on disposal of opioids
Description: Current class curriculum including education about pain management with additional education about the disposal of opioids.
Study NCT03046537 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Breath test
Description: Collecting breath test from participants
Study NCT03513978 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: IAI Exercises Protocol
Description: Progressive exercises to improve the strength and propioception of the male soccer players.
Study NCT03513978 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: FIFA 11+
Description: Progressive exercises protocol to prevent injuries in male soccer players which has been created by FIFA. It is based in different body wieght exercises to improve the neuromuscular control and stabilization.
Study NCT03175445 — intervention group
Intervention type: OTHER
Intervention: CBCT scan by planmeca promax
Description: software measurement tool of CBCT
Study NCT00454311 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Biopsy of Day 3 Embryo